Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02730403 · ClinicalTrials.gov registry record
TAU Opioid Use Outcomes Following Discharge From Detoxification and Short Term Residential Programs Affiliated With CTN-0051
A clinical trial, sponsored by NYU Langone Health.
- Completed
- Registry status
- 211
- Enrollment target
NCT02730403 is a clinical trial that has completed, run by NYU Langone Health. The registered enrollment target is 211 participants.
The verdict
NCT02730403 has completed, sponsored by NYU Langone Health.
- COMPLETED
- Registry status
- 211 participants
- Enrollment target
Study Summary
This is an observational, "ancillary study" intended to describe opioid use among opioid use disorder patients following their discharge into the community from inpatient detoxification and/or short-term residential treatment programs affiliated with parent study CTN-0051, which assessed the comparative effectiveness of extended release injectable naltrexone (XR-NTX, Vivitrol®), an opioid antagonist recently approved and indicated for the prevention of relapse to opioid dependence, versus buprenorphine-naloxone (BUP-NX, Suboxone®), a high affinity partial agonist indicated for maintenance treatment of opioid dependence, as pharmacotherapeutic aids to recovery.
Interventions
- OTHER Treatment As Usual
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 211 participants |
| Start Date | 2016-06-01 |
| Est. Completion | 2017-01-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02730403
The ClinicalTrials.gov registry entry for NCT02730403 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 211 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Treatment As Usual is the first listed.
NCT02730403 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02730403 about?
NCT02730403 is a clinical study titled "TAU Opioid Use Outcomes Following Discharge From Detoxification and Short Term Residential Programs Affiliated With CTN-0051". This is an observational, "ancillary study" intended to describe opioid use among opioid use disorder patients following their discharge into the community from inpatient detoxification and/or short-term residential treatment programs affiliated with parent study CTN-0051, which assessed the compara...
What is the current status of trial NCT02730403?
This trial is currently completed. The enrollment target is 211 participants. The study started on 2016-06-01. Estimated completion is 2017-01-30.
What interventions are being tested in trial NCT02730403?
The interventions under investigation include: Treatment As Usual (OTHER).
Who is sponsoring clinical trial NCT02730403?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.